Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults

IMPORTANCE: Rituximab is among the most frequently used immunotherapies in pediatrics. Few studies have reported long-term adverse events associated with its use for children. OBJECTIVE: To describe the use of rituximab and to assess whether its use is associated with short- or long-term adverse eve...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Netw Open
Auteurs principaux: McAtee, Casey Lee, Lubega, Joseph, Underbrink, Kristen, Curry, Kristen, Msaouel, Pavlos, Barrow, Martha, Muscal, Eyal, Lotze, Timothy, Srivaths, Poyyapakkam, Forbes, Lisa R., Allen, Carl, Bernhardt, M. Brooke
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2021
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859842/
https://ncbi.nlm.nih.gov/pubmed/33533931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.36321
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires